After pushing addictive OxyContin, Purdue now pursuing overdose antidote | Ars Technica

Notorious OxyContin-maker Purdue Pharma—which has been widely criticized for deceptively marketing its highly addictive painkiller and for its role in spurring the current nationwide epidemic of opioid abuse and overdose deaths—is moving ahead with a new, potent drug, one said to be an antidote to opioid overdoses.

Source: After pushing addictive OxyContin, Purdue now pursuing overdose antidote | Ars Technica

Leave a Reply

Your email address will not be published. Required fields are marked *

1 × 1 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.